DNA Methyltransferase 1
DNMT1geneDNMT1 maintains DNA methylation patterns controlling expression of miR-520e and inflammatory mediators in atherosclerotic plaque cells.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleEpigenetic regulator of miR-520e and inflammatory gene expression in plaques.
Also acts inLipid entry/oxidation
Druggability
DruggableYes
Known drugs / candidates2
Small-molecule tractableYes
Antibody tractableNo
EnsemblENSG00000130816
Type I vs non-Type I discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I35
C — non-Type-I64
A — assay feasibility52
E — evidence strength25
T1DI (composite)5
Specificity differential (R−C)-29.7
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
No non-Type-I axis evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- miR-520e and its promoter region DNA methylation as potential biomarkers in atherosclerosis.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2024 · PMID 38917487 · doi